Deerfield Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-109,536
Closed -$663K 455
2024
Q2
$663K Buy
109,536
+62,945
+135% +$388K 0.01% 208
2024
Q1
$273K Buy
46,591
+31,239
+203% +$186K ﹤0.01% 275
2023
Q4
$120K Buy
+15,352
New +$106K ﹤0.01% 202
2014
Q4
Sell
-682,740
Closed -$9.37M 114
2014
Q3
$9.37M Buy
+682,740
New +$9.74M 0.34% 72
2013
Q4
Sell
-2,013,104
Closed -$26.6M 110
2013
Q3
$26.6M Sell
2,013,104
-638,362
-24% -$7.53M 1.24% 34
2013
Q2
$29.9M Buy
+2,651,466
New +$28.2M 1.41% 25

Other funds holding ANGO

Deerfield Management's ANGO Position: Q3 2024 in Review

Deerfield Management sold out of AngioDynamics (ANGO) in Q3 2024, closing a stake of 109,536 shares — an estimated $663K sold.

Deerfield Management first reported a position in ANGO in Q2 2013 and held it in 6 quarters. The position peaked at $29.9M in Q2 2013. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2024.

  • Deerfield Management reported no remaining AngioDynamics position as of Q3 2024 after selling out during the quarter.
  • Deerfield Management sold 109,536 AngioDynamics shares in Q3 2024, an estimated $663K.
  • Deerfield Management first reported a position in AngioDynamics in Q2 2013 and held it in 6 quarters.
  • Deerfield Management's AngioDynamics position peaked at $29.9M in Q2 2013.
  • 138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.